阿里健康与诺华达成数字化慢病合作共建慢性荨麻疹院外管理新模式

人民财讯03-25

记者3月25日获悉，阿里健康与诺华制药宣布在慢性自发性荨麻疹（CSU）领域达成数字化慢病合作。双方将围绕诺华旗下全球首个口服荨麻疹靶向药瑞米布替尼片（商品名：瑞普多®），依托阿里健康的数字化平台能力，提供从疾病科普、用药指导到全周期健康管理的整合式服务。阿里健康依托其长期深耕的“全周期慢病管理体系”，为患者打造一个“院外第二诊室”。（文章来源：人民财讯）

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2622302684?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-25 16:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622302684","market":"hk","top_or_hot":-1,"title":"阿里健康与诺华达成数字化慢病合作 共建慢性荨麻疹院外管理新模式","media":"人民财讯","content":"<div>\n<p>记者3月25日获悉，阿里健康与诺华制药宣布在慢性自发性荨麻疹（CSU）领域达成数字化慢病合作。双方将围绕诺华旗下全球首个口服荨麻疹靶向药瑞米布替尼片（商品名：瑞普多®），依托阿里健康的数字化平台能力，提供从疾病科普、用药指导到全周期健康管理的整合式服务。阿里健康依托其长期深耕的“全周期慢病管理体系”，为患者打造一个“院外第二诊室”。 （文章来源：人民财讯）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202603253684062712.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>阿里健康与诺华达成数字化慢病合作 共建慢性荨麻疹院外管理新模式</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n阿里健康与诺华达成数字化慢病合作 共建慢性荨麻疹院外管理新模式\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-25 16:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202603253684062712.html><strong>人民财讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>记者3月25日获悉，阿里健康与诺华制药宣布在慢性自发性荨麻疹（CSU）领域达成数字化慢病合作。双方将围绕诺华旗下全球首个口服荨麻疹靶向药瑞米布替尼片（商品名：瑞普多®），依托阿里健康的数字化平台能力，提供从疾病科普、用药指导到全周期健康管理的整合式服务。阿里健康依托其长期深耕的“全周期慢病管理体系”，为患者打造一个“院外第二诊室”。 （文章来源：人民财讯）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202603253684062712.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1142","symbol_name":"互联网与直销零售","start_time":0,"source_url":"http://finance.eastmoney.com/a/202603253684062712.html","article_id":"2622302684","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622302684","pubTimestamp":1774427820,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"【阿里健康与诺华达成数字化慢病合作 共建慢性荨麻疹院外管理新模式】记者3月25日获悉，阿里健康与诺华制药宣布在慢性自发性荨麻疹（CSU）领域达成数字化慢病合作。双方将围绕诺华旗下全球首个口服荨麻疹靶向药瑞米布替尼片（商品名：瑞普多），依托阿里健康的数字化平台能力，提供从疾病科普、用药指导到全周期健康管理的整合式服务。阿里健康依托其长期深耕的“全周期慢病管理体系”，为患者打造一个“院外第二诊室”。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1142":"互联网与直销零售","BK1189":"医疗保健技术","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","BK1617":"AI医疗","BK4007":"制药","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","00241":"阿里健康","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK1610":"ETF&股票定投概念","BK4532":"文艺复兴科技持仓","BK1615":"港股-互联网","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","BK1584":"蚂蚁金服概念","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK1571":"互联网医疗","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","BK1515":"抗疫概念","BK4585":"ETF&股票定投概念","BK1591":"就地过年概念","BK1247":"药品零售","NVS":"诺华","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK4578":"CAR-T","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","BK1502":"双十一","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","BK1501":"阿里概念股","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","BK4588":"碎股","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK1589":"北水核心资产"},"translate_title":"Alibaba Health and Novartis reach digital chronic disease cooperation to jointly build a new model of out-of-hospital management of chronic urticaria","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVS":1.5,"00241":1.5},"content_text":"记者3月25日获悉，阿里健康与诺华制药宣布在慢性自发性荨麻疹（CSU）领域达成数字化慢病合作。双方将围绕诺华旗下全球首个口服荨麻疹靶向药瑞米布替尼片（商品名：瑞普多®），依托阿里健康的数字化平台能力，提供从疾病科普、用药指导到全周期健康管理的整合式服务。阿里健康依托其长期深耕的“全周期慢病管理体系”，为患者打造一个“院外第二诊室”。 （文章来源：人民财讯）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622302684","isCrawlerRequest":true}

阿里健康与诺华达成数字化慢病合作 共建慢性荨麻疹院外管理新模式

精彩评论

阿里健康与诺华达成数字化慢病合作共建慢性荨麻疹院外管理新模式